ReviewNeurological research and practice2021

Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis.

Maike F Dohrn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.